# Glycostasis, Inc. — Form D

Glycostasis, Inc. of SEATTLE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2015-06-11. The offering totals $2.7M, of which $150K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2015-06-11
- Form: D
- Accession: 0001644472-15-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $2.7M
- Amount sold: $150K
- Remaining: $2.5M
- Investors: 1
- Date of first sale: 2015-05-28
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-241544

## Issuer

- Name: Glycostasis, Inc.
- CIK: 0001644472
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2012
- Address: 4317 DENSMORE AVE. N., SEATTLE, WA, 98103
- Phone: 425-591-9641

## Officers, directors & promoters (3)

| Name | Role | Location |
| --- | --- | --- |
| John Mulligan | Director | Seattle, WA |
| John Mulligan | Executive Officer | Seattle, WA |
| John Mulligan | Promoter | Seattle, WA |

## More

- [CIK 1644472 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1644472&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001644472-15-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.